| Real world hybrid closed‐loop discontinuation: predictors and perceptions of youth discontinuing the 670G system in the first 6 months LH Messer, C Berget, T Vigers, L Pyle, C Geno, RP Wadwa, KA Driscoll, ... Pediatric diabetes 21 (2), 319-327, 2020 | 141 | 2020 |
| Six months of hybrid closed loop in the real‐world: an evaluation of children and young adults using the 670G system C Berget, LH Messer, T Vigers, BI Frohnert, L Pyle, RP Wadwa, ... Pediatric diabetes 21 (2), 310-318, 2020 | 124 | 2020 |
| Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline CL Chan, T Vigers, L Pyle, PS Zeitler, SD Sagel, KJ Nadeau Journal of Cystic Fibrosis 17 (6), 783-790, 2018 | 74 | 2018 |
| cgmanalysis: an R package for descriptive analysis of continuous glucose monitor data T Vigers, CL Chan, J Snell-Bergeon, P Bjornstad, PS Zeitler, G Forlenza, ... PLoS One 14 (10), e0216851, 2019 | 57 | 2019 |
| Hemoglobin A1c accurately predicts continuous glucose monitoring–derived average glucose in youth and young adults with cystic fibrosis CL Chan, E Hope, J Thurston, T Vigers, L Pyle, PS Zeitler, KJ Nadeau Diabetes Care 41 (7), 1406-1413, 2018 | 53 | 2018 |
| Real-world use of a new hybrid closed loop improves glycemic control in youth with type 1 diabetes LH Messer, C Berget, L Pyle, T Vigers, E Cobry, KA Driscoll, GP Forlenza Diabetes Technology & Therapeutics 23 (12), 837-843, 2021 | 48 | 2021 |
| Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor A Li, T Vigers, L Pyle, E Zemanick, K Nadeau, SD Sagel, CL Chan Journal of Cystic Fibrosis 18 (1), 144-149, 2019 | 44 | 2019 |
| Type 1 diabetes onset at young age is associated with compromised bone quality VN Shah, P Joshee, R Sippl, L Pyle, T Vigers, RD Carpenter, W Kohrt, ... Bone 123, 260-264, 2019 | 38 | 2019 |
| Real‐world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: identifying a clinical target for hybrid closed‐loop use C Berget, HK Akturk, LH Messer, T Vigers, L Pyle, J Snell‐Bergeon, ... Diabetes, Obesity and Metabolism 23 (9), 2048-2057, 2021 | 36 | 2021 |
| Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS‐HS index) AM Carreau, L Pyle, Y Garcia‐Reyes, H Rahat, T Vigers, T Jensen, ... Clinical endocrinology 91 (4), 544-552, 2019 | 30 | 2019 |
| Screening for cystic fibrosis‐related diabetes and prediabetes: evaluating 1, 5‐anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c KL Tommerdahl, JT Brinton, T Vigers, KJ Nadeau, PS Zeitler, CL Chan Pediatric diabetes 20 (8), 1080-1086, 2019 | 22 | 2019 |
| The relationship between continuous glucose monitoring and OGTT in youth and young adults with cystic fibrosis CL Chan, L Pyle, T Vigers, PS Zeitler, KJ Nadeau The Journal of Clinical Endocrinology & Metabolism 107 (2), e548-e560, 2022 | 19 | 2022 |
| Pediatric Medicaid patients with type 1 diabetes benefit from continuous glucose monitor technology SJ Ravi, A Coakley, T Vigers, L Pyle, GP Forlenza, T Alonso Journal of diabetes science and technology 15 (3), 630-635, 2021 | 19 | 2021 |
| Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index KL Tommerdahl, JT Brinton, T Vigers, M Cree-Green, PS Zeitler, ... Journal of Cystic Fibrosis 20 (2), 339-345, 2021 | 19 | 2021 |
| Discordance between glucose management indicator and glycated hemoglobin in people without diabetes VN Shah, T Vigers, L Pyle, P Calhoun, RM Bergenstal Diabetes Technology & Therapeutics 25 (5), 324-328, 2023 | 14 | 2023 |
| Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis CL Chan, A Granados, A Moheet, S Singh, T Vigers, AM Arbeláez, Y Yi, ... Journal of clinical & translational endocrinology 30, 100311, 2022 | 14 | 2022 |
| Structural lesions on kidney biopsy in youth-onset and adult-onset type 2 diabetes HC Looker, L Pyle, T Vigers, C Severn, PJ Saulnier, B Najafian, M Mauer, ... Diabetes Care 45 (2), 436-443, 2022 | 14 | 2022 |
| Ultra rapid-acting inhaled insulin improves glucose control in patients with type 2 diabetes mellitus P Levin, BJ Hoogwerf, J Snell-Bergeon, T Vigers, L Pyle, L Bromberger Endocrine Practice 27 (5), 449-454, 2021 | 14 | 2021 |
| Predicting success with a first-generation hybrid closed-loop artificial pancreas system among children, adolescents, and young adults with type 1 diabetes: a model development … GP Forlenza, T Vigers, C Berget, LH Messer, RA Lal, M Basina, ... Diabetes Technology & Therapeutics 24 (3), 157-166, 2022 | 13 | 2022 |
| The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis A Granados, CL Chan, A Moheet, T Vigers, AM Arbeláez, K Larson Ode Pediatric pulmonology 58 (6), 1805-1811, 2023 | 11 | 2023 |
